Inogen Inc (INGN)
8.64
+0.03
(+0.35%)
USD |
NASDAQ |
May 22, 16:00
8.64
0.00 (0.00%)
After-Hours: 20:00
Inogen Enterprise Value: 83.90M for May 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 22, 2024 | 83.90M |
| May 21, 2024 | 83.19M |
| May 20, 2024 | 86.73M |
| May 17, 2024 | 88.38M |
| May 16, 2024 | 91.21M |
| May 15, 2024 | 88.62M |
| May 14, 2024 | 90.50M |
| May 13, 2024 | 88.03M |
| May 10, 2024 | 79.66M |
| May 09, 2024 | 85.08M |
| May 08, 2024 | 74.47M |
| May 07, 2024 | 52.31M |
| May 06, 2024 | 49.71M |
| May 03, 2024 | 48.77M |
| May 02, 2024 | 45.73M |
| May 01, 2024 | 46.20M |
| April 30, 2024 | 40.31M |
| April 29, 2024 | 45.49M |
| April 26, 2024 | 39.84M |
| April 25, 2024 | 32.78M |
| April 24, 2024 | 46.20M |
| April 23, 2024 | 42.67M |
| April 22, 2024 | 37.96M |
| April 19, 2024 | 39.14M |
| April 18, 2024 | 47.14M |
| Date | Value |
|---|---|
| April 17, 2024 | 43.85M |
| April 16, 2024 | 43.38M |
| April 15, 2024 | 48.79M |
| April 12, 2024 | 53.50M |
| April 11, 2024 | 51.62M |
| April 10, 2024 | 54.44M |
| April 09, 2024 | 61.98M |
| April 08, 2024 | 31.60M |
| April 05, 2024 | 28.54M |
| April 04, 2024 | 36.78M |
| April 03, 2024 | 43.61M |
| April 02, 2024 | 47.14M |
| April 01, 2024 | 57.74M |
| March 31, 2024 | 70.22M |
| March 28, 2024 | 59.78M |
| March 27, 2024 | 57.33M |
| March 26, 2024 | 52.08M |
| March 25, 2024 | 46.95M |
| March 22, 2024 | 36.45M |
| March 21, 2024 | 37.62M |
| March 20, 2024 | 32.25M |
| March 19, 2024 | 31.32M |
| March 18, 2024 | 31.08M |
| March 15, 2024 | 32.48M |
| March 14, 2024 | 28.98M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-50.93M
Minimum
Sep 25 2023
1.610B
Maximum
Aug 04 2021
544.95M
Average
473.25M
Median
Enterprise Value Benchmarks
| Oragenics Inc | 10.89M |
| Palatin Technologies Inc | 22.90M |
| vTv Therapeutics Inc | 23.51M |
| G1 Therapeutics Inc | 203.24M |
| Vera Therapeutics Inc | 1.723B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.58M |
| Revenue (Quarterly) | 78.02M |
| Total Expenses (Quarterly) | 94.30M |
| EPS Diluted (Quarterly) | -0.62 |
| Gross Profit Margin (Quarterly) | 44.05% |
| Profit Margin (Quarterly) | -18.68% |
| Earnings Yield | -48.03% |
| Normalized Earnings Yield | -35.09 |